Position in BNTX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$9,305
+$417 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#237
of 282 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NBC SECURITIES, INC. holds $5,111,855 across 54 Biotechnology names. BNTX ranks #37 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
10,414 | $815,103 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,623 | $397,261 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
55,022 | $374,699 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
3,900 | $369,525 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
2,545 | $311,966 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
2,591 | $303,328 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
435 | $271,239 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
4,479 | $246,345 |
All Filings in BNTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,305 | 100 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $8,888 | 100 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $9,520 | 100 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $9,862 | 100 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,647 | 100 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $9,106 | 100 | Shares | Sole | 2025-04-09 | |
| 2024-09-30 | $12,708 | 107 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $8,036 | 100 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $9,225 | 100 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $5,065 | 48 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1 | 15 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||